What changed in this filing

/stocks — the workspaceLOADING

Item 1A. Risk Factors

2024-05-08 compared with 2024-02-06 · 124 added, 2 removed, 2 unchanged (98% of the section changed)

1 unchanged sentence

regulation, and (iv) our common stock.

There have been no material changes from the risk factors previously disclosed in our Annual

Report on Form 10-K for the fiscal year ended June 30, 2023.

as set forth below, there have been no material

changes from the risk factors previously

disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30,

operations and stock price.

The completion

Adumo acquisition

is subject to

conditions precedent,

including receipt

of shareholder

regulatory approvals and certain third-party consents.

Some of these conditions

are outside our control.

consideration of the purchase price.

Under the terms of the of the transaction agreement we need to obtained

this approval by no later

certain materials

shareholders in

the shares to

the Adumo sellers.

engage external

service providers

preparation and

distribution of these materials.

The transaction may fail if

we are unable to prepare

these materials in a timely manner

and obtain the

necessary shareholder approvals.

governmental and regulatory authorities.

The regulatory approval processes may

take a lengthy period of time to complete,

can be no assurance

as to the outcome

of the approval processes,

including the undertakings

and conditions that

may be required for

approval, or whether the regulatory approvals will be obtained at all.

the completion

acquisition is

other things,

or circumstance

occurring that

would result in a material adverse effect on the Adumo’s

business operations or financial results.

provide any assurance regarding if or

when all conditions precedent to the acquisition

will be satisfied or waived.

for any reason, the acquisition is

not completed, or its completion is materially

delayed and/or the transaction agreement is terminated,

the market price of our common stock may be materially and adversely

In addition, if the acquisition is not completed for any reason, there are risks that (i) the announcement of the acquisition and (ii)

the dedication

of management’s

attention and other

of our resources

to the completion

thereof, could

have a negative

impact on our

relationships with our stakeholders

and could have a material

adverse effect on

our current and future operations,

financial condition

and prospects.

We may not realize some

or all of the anticipated benefits from the Adumo acquisition.

Even if we complete the

Adumo acquisition, we may experience

unforeseen events, changes or

circumstances that may adversely

For example, we may incur unexpected costs, charges or expenses

resulting from the transaction, including charges to future

earnings if Adumo’s business

does not perform as expected.

Our expectations regarding

Adumo’s business and prospects may not

associated with

service offerings

of operations,

including the

regulatory rules required to operate its business.

Further, there are

numerous challenges, risks

involved with integrating

the operations

of Adumo with

integrating Adumo into

our company will require

significant attention from our

senior management which

may divert their attention

organizations and the necessity of retaining and integrating personnel,

including Adumo’s key employees.

Our Sarbanes-Oxley

2002 (“Sarbanes”)

management certification

attestation regarding

the effectiveness

financial reporting

likely exclude

the operations

close the transaction in fiscal 2025.

The requirement to evaluate and report on our internal controls

also applies to companies that we

As a group of South

African private companies, Adumo is not required to

comply with Sarbanes prior to the

time we acquired

reporting would

integrate the operations of Adumo into our internal control over

financial reporting for fiscal 2025, our internal control over financial

reporting may not be effective.

If some or all

of the aforementioned or

other risks materialize, our

ability to realize the

anticipated benefits of

Adumo could be

materially impaired, and as a result, our financial condition, results of operations,

cash flows and stock price could suffer.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1A. Risk Factors